Stokes Capital Advisors LLC boosted its position in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 53.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 55,055 shares of the company’s stock after purchasing an additional 19,184 shares during the period. Stokes Capital Advisors LLC’s holdings in Colgate-Palmolive were worth $4,697,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. RFG Bristol Wealth Advisors LLC boosted its position in shares of Colgate-Palmolive by 99.2% during the third quarter. RFG Bristol Wealth Advisors LLC now owns 6,375 shares of the company’s stock valued at $544,000 after buying an additional 3,175 shares during the period. GK Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive in the third quarter worth approximately $53,000. Castle Rock Wealth Management LLC lifted its stake in shares of Colgate-Palmolive by 42.1% during the 3rd quarter. Castle Rock Wealth Management LLC now owns 11,789 shares of the company’s stock worth $1,006,000 after acquiring an additional 3,491 shares during the last quarter. Lincoln Capital LLC boosted its holdings in Colgate-Palmolive by 41.7% during the 3rd quarter. Lincoln Capital LLC now owns 8,129 shares of the company’s stock valued at $694,000 after acquiring an additional 2,392 shares during the period. Finally, Bullock Wealth Management Group boosted its holdings in Colgate-Palmolive by 334.0% during the 3rd quarter. Bullock Wealth Management Group now owns 3,598 shares of the company’s stock valued at $307,000 after acquiring an additional 2,769 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In related news, Director John T. Cahill sold 4,170 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $93.37, for a total transaction of $389,352.90. Following the transaction, the director directly owned 28,373 shares of the company’s stock, valued at $2,649,187.01. This trade represents a 12.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, COO Panagiotis Tsourapas sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $92.05, for a total transaction of $920,500.00. Following the completion of the transaction, the chief operating officer directly owned 64,901 shares of the company’s stock, valued at $5,974,137.05. This trade represents a 13.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 175,191 shares of company stock worth $16,110,903. 0.43% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
View Our Latest Stock Analysis on CL
Colgate-Palmolive Price Performance
Shares of CL stock opened at $88.19 on Friday. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The company has a current ratio of 1.03, a quick ratio of 0.67 and a debt-to-equity ratio of 13.82. The stock has a fifty day simple moving average of $89.10 and a two-hundred day simple moving average of $88.77. The stock has a market capitalization of $70.31 billion, a price-to-earnings ratio of 35.00, a P/E/G ratio of 4.11 and a beta of 0.33.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings results on Friday, July 31st. The company reported $0.99 EPS for the quarter, beating the consensus estimate of $0.95 by $0.04. The firm had revenue of $5.36 billion for the quarter, compared to analyst estimates of $5.36 billion. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%. The business’s revenue for the quarter was up 4.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.92 earnings per share. On average, analysts predict that Colgate-Palmolive Company will post 3.87 EPS for the current fiscal year.
Colgate-Palmolive Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be given a dividend of $0.53 per share. The ex-dividend date of this dividend is Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.4%. Colgate-Palmolive’s dividend payout ratio (DPR) is 84.13%.
Colgate-Palmolive Profile
Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.
The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.
Read More
- Five stocks we like better than Colgate-Palmolive
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
